All
Search
Images
Videos
Maps
News
More
Shopping
Flights
Travel
Hotels
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
FDA June 2024: Key Approvals and Designations Propel Oncological
…
Jul 2, 2024
targetedonc.com
Drawing Comparisons for Relevant Therapies in Patients With DLBCL
7 months ago
targetedonc.com
Steroid-Refractory Acute Graft-Versus-Host Disease Defined
Mar 22, 2021
targetedonc.com
SWOG S1826: Frontline N-AVD vs BV-AVD in Advanced Hodgkin’s L
…
Aug 31, 2023
targetedonc.com
Atezolizumab/Bevacizumab for HCC: Toxicity Management
Nov 5, 2020
targetedonc.com
CHRYSALIS-2: Amivantamab Lazertinib in Non–Small Cell Lung
…
Sep 21, 2023
targetedonc.com
Risk of Recurrence in Stage 3B CRC
Oct 7, 2016
targetedonc.com
Sequencing KRAS-Targeted Therapy in G12C Mutated NSCLC
Feb 21, 2024
targetedonc.com
Navigating ICI Plus TKI Combinations for First-Line mRCC
…
9 months ago
targetedonc.com
The Targeted Pulse: Explore How a Community Practice Implemented
…
8 months ago
targetedonc.com
The Targeted Pulse: Advancements in CLL, RCC, CRC, and More
1 week ago
targetedonc.com
Belumosudil Shows Sustained Efficacy and Safety for Chronic G
…
Mar 11, 2024
targetedonc.com
Challenges Facing Cancer Survivors
9 months ago
targetedonc.com
Nirogacestat Shows Statistically Significant Improvements in Desm
…
Nov 28, 2023
targetedonc.com
Safety Challenges of Oncolytic Virus Therapy
Jun 12, 2024
targetedonc.com
The Role of Menin Inhibitors in AML
Nov 1, 2022
targetedonc.com
An Introduction to Front-line Nivolumab/Ipilimumab Therapy fo
…
6 months ago
targetedonc.com
Monitoring Mantle Cell Lymphoma: PET Scans and MRD
Sep 13, 2017
targetedonc.com
Review of Phase 3 Data on Investigational Endocrine Agents:
…
5 days ago
targetedonc.com
Behind the FDA Approval: Dr Poh on Tafasitamab in FL
2 weeks ago
targetedonc.com
Options for MRD Testing Affect Patient Treatment Plan in Lung Ca
…
6 months ago
targetedonc.com
Case Presentation: 74-Year-Old Man With Relapsed/Refractory Follicul
…
Apr 22, 2021
targetedonc.com
First-Line Combination Therapy for EGFR-mutated Metastatic NSCLC
…
4 months ago
targetedonc.com
Myeloma Community Responds Positively to Expanding Role of M
…
1 month ago
targetedonc.com
BrECADD Shows Promise as New Standard for Advanced Hodgkin L
…
Jun 1, 2024
targetedonc.com
INAVO120: Inavolisib Combination Therapy in PIK3CA-Mutated Breas
…
Jun 17, 2024
targetedonc.com
Phase 3 NATALEE Study Assesses Ribociclib Plus ET in Early Breast
…
Jul 1, 2023
targetedonc.com
Unmet Needs Persist for Patients with Melanoma
11 months ago
targetedonc.com
Program Development and SOPs for Bispecific Engagers
Dec 14, 2023
targetedonc.com
T-DXd Shows Promise in Treating HER2 Breast Cancer With Brain M
…
9 months ago
targetedonc.com
See more videos
More like this
Feedback
Feedback